Company Information
CIN
Status
Date of Incorporation
23 February 2017
State / ROC
/ ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
15 September 2023
Paid Up Capital
359,962,670
Authorised Capital
1,200,000,000
Directors
Rajiv Vijay Nabar
Director/Designated Partner
almost 2 years ago
almost 2 years ago
Rajendra Kumar Srivastava
Director/Designated Partner
almost 2 years ago
almost 2 years ago
Patri Venkat Raghavendra Rao
Manager/Secretary
about 2 years ago
about 2 years ago
Rajender Juvvadi Rao
Director/Designated Partner
about 2 years ago
about 2 years ago
Kausalya Santhanam
Director/Designated Partner
over 2 years ago
over 2 years ago
Kartheek Chintalapati Raju
Director/Designated Partner
over 2 years ago
over 2 years ago
Poorvank Purohit
Director/Designated Partner
over 2 years ago
over 2 years ago
Ankur Nand Thadani
Director/Designated Partner
over 2 years ago
over 2 years ago
Subramanian Hariharan
Director/Designated Partner
over 2 years ago
over 2 years ago
Aditya Puri
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Jitesh Devendra
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Vineeta Rai
Director/Designated Partner
about 4 years ago
about 4 years ago
Arun Kumar Pillai
Director/Designated Partner
about 4 years ago
about 4 years ago
Bharath Ramraman Sesha
Director/Designated Partner
over 4 years ago
over 4 years ago
Subhash Chand Anand
Director/Designated Partner
over 4 years ago
over 4 years ago
K R Ravishankar
Director/Designated Partner
about 6 years ago
about 6 years ago
Ramakrishnan Rajagopal
Director/Designated Partner
about 7 years ago
about 7 years ago
Nirmal Pratap Bhogilal
Director/Designated Partner
about 7 years ago
about 7 years ago
Jagdish Viswanath Dore
Additional Director
over 7 years ago
over 7 years ago
Patents
The present invention relates to an improved process for the purification of Mesalamine or the preparation of crystalline Mesalamine, particularly purification of Mesalamine or the preparation of crystalline Mesalamine for the pharmaceutical preparations.
The present invention relates to an improved process for the preparation of Ertugliflozin or its pharmaceutically acceptable salt thereof.
The present invention relates to premix or solid dispersion of Valbenazine or a salt thereof in combination with one or more pharmaceutically acceptable excipients and methods for preparation thereof. More particularly, the present invention relates to premix or solid dispersion of Valbenazine ditosylate in combinat...
The present invention relates to an improved process for the preparation of Edaravone that is simple and economically significant. This improved process also includes purification of Edaravone.
The present invention provides a novel process for the preparation of Pemafibrate and a novel polymorphic form S of Pemafibrate and a process for preparing the said novel polymorphic form S of Pemafibrate.
The present invention provides a purification process for folinic acid salts thereof, preferably calcium and sodium comprising the steps of washing solid folinic acid salt with a mixture of cyclohexane and alcohol and also a process for the preparation of pure calcium folinate from sodium folinate.
...
The present invention relates to an improved process for the preparation of Losartan potassium.
The present invention relates to an improved process for the preparation of Obeticholic acid and intermediates used in the process thereof. The invention also relates to a solid form of tertiary butylamine salt of Obeticholic acid and tertiary butylamine salt of Obeticholic acid in the solvate form.
...
The present invention provides an improved process for the preparation of Brivaracetam and the intermediates useful for the preparation of Brivaracetam.
The present invention relates to an improved process for the preparation of benznidazole and its crystalline Form M2.
The present invention relates to an improved process for the preparation of Obeticholic acid and intermediates used in the process thereof. The invention also relates to a solid form of tertiary butylamine salt of Obeticholic acid and tertiary butylamine salt of Obeticholic acid in the solvate form.
...
The present application relates to a commercially viable process for the preparation of Patiromer, a crosslinked polymer. More particularly the present application relates to a commercially viable process for the preparation of Patiromer sorbitex calcium, an active ingredient useful in the treatment of hyperkalemia....
The present invention relates to a novel process for the preparation of Rotigotine of formula (I) and intermediates thereof.
The present invention relates to an improved process for the preparation of Fingolimod or pharmaceutically acceptable salts and its intermediates thereof.
The present invention relates to a process for the preparation of Sevelamer carbonate from polyallylamine hydrochloride.
The present invention provides an improved process for the preparation of polyallylamine or its salts thereof having an average molecular weight not less than 15,000 Daltons and a Poly Dispersity Index of not more than 5, and purification process for the same thereof.
The present invention relates to an improved process for the preparation of Chlorthalidone and its intermediates thereof.
The present application provides a process for the preparation of Sugammadex or a pharmaceutically acceptable salt thereof. More particularly the present application relates to a commercially advantageous and industrially viable process for preparing Sugammadex sodium.
The present invention relates to an improved process for the preparation of Nintedanib esylate.
The invention relates to an improved process for the preparation of Dolutegravir sodium and its intermediates thereof.
The present invention relates to an improved process for the preparation of Chlorpromazine or its pharmaceutically acceptable salts thereof, preferably process for the preparation of Chlorpromazine or its pharmaceutically acceptable salts thereof having high purity.
The present invention relates to a process for the preparation of Mebendazole of Formula-I comprising the step of reacting 3,4-Diaminobenzophenone of Formula-II with 1,3-Bis(methoxycarbonyl)-2-decyl-2-thiopseudourea of Formula-III.
The present application provides an improved process for the preparation of Safinamide or a pharmaceutically acceptable salt thereof. More particularly the present application relates to an improved, commercially advantageous and industrially viable process for preparing Safinamide mesylate in high yield and purity....
The present invention relates to a premix of Ertugliflozin with one or more pharmaceutically acceptable excipients and the process for preparing the same.
The invention relates to an improved process for purification of Dipyridamole. More particularly, the invention relates to a process for preparing purified Dipyridamole, having total impurities not more than 0.50% w/w and any individual impurity not more than 0.1 % w/w.
ABSTRACT
AN IMPROVED PROCESS FOR THE PREPARATION OF BUSPIRONE
HYDROCHLORIDE
The present invention relates to an improved process for the preparation of Buspirone hydrochloride particularly useful in large scale production.
The present invention relates to an improved process for the preparation of Stiripentol particles having defined particle size distribution, such that D90 of the particles is less than 300 µm and D50 of the particles is less than 100 µm.
The present invention relates to an improved process for the preparation of Sodium Zirconium Cyclosilicate.
The present invention relates to a process for the preparation of iron (III)-based phosphate adsorbent. More particularly, the present invention relates to an improved process for the preparation of Sucroferric oxyhydroxide, suitable for large scale manufacturing.
The present application provides a process for the preparation of Cevimeline or a pharmaceutically acceptable salt thereof. More particularly the present application relates to an improved, commercially advantageous and industrially viable process for preparing Cevimeline hydrochloride hemihydrate in high yield and ...
The present invention discloses an improved process for the preparation of crystal form of sodium zirconium cyclosilicate. The process for preparation of sodium zirconium cyclosilicate disclosed in prior arts is difficult to prepare in smaller reaction vessel, however, the present invention is achieved the in a smal...
The present invention relates to an efficient, simple, cost effective and industrial viable process for the purification of Sugammadex sodium. More particularly, the present invention provides an improved drying process for Sugammadex sodium for reducing the residual organic solvents.
The present invention relates to an improved process for the preparation of Rotigotine and of intermediates thereof, which is cost effective and economically significant.
The present invention relates to solid forms of Baloxavir marboxil, processes for preparing the solid forms, and pharmaceutical compositions thereof.
The present invention relates to improved processes for the preparation of Ergocalciferol. The invention also provides a process for purification of Ergocalciferol.
The present invention relates to a novel process for the preparation of sodium zirconium cyclosilicate, more specifically ZS-9 form of sodium zirconium cyclosilicate which is substantially free from other forms such as ZS-7 and ZS-8 and having less metal impurities, particularly lead impurities less than about 0.5 p...
The present invention relates to a novel process for the preparation of tranexamic acid, particularly from 1,4-cyclohexanedimethanol. More specifically the present invention relates to a novel process for the preparation of an intermediates of tranexamic acid.
The invention discloses a novel process for the preparation of Atracurium besylate. More particularly, the invention discloses a novel process for the preparation of freeze-dried composition of Atracurium besylate.
The present invention relates to a process for the preparation of cisatracurium besylate and its intermediates thereof. Particularly, the present invention relates to a process for the preparation of (R)-tetrahydropapaverine or its salts or an intermediate useful for the preparation of cisatracurium and atracurium b...
The present invention relates to an improved, economically significant, and advantageous process for the preparation of Colesevelam hydrochloride of formula (I).
The present invention relates to an improved process for the preparation of rotigotine, which is feasible for plant batches, eco-friendly, and also economically significant.
The present invention relates to a novel process for the preparation of tranexamic acid, particularly from 1,4-cyclohexanedimethanol. More specifically the present invention provides a novel process for the preparation of intermediates of tranexamic acid.
The present invention relates to an improved process for the preparation of migalastat or its pharmaceutical acceptable salts and its intermediates thereof, particularly related to a chemoenzymatic process for the preparation of amine intermediate of migalastat from keto intermediate of migalastat by using transamin...
The present invention relates to a process for the preparation of Atracurium besylate. More particularly, the present invention relates to a process for the preparation of freeze-dried composition of Atracurium besylate.
The present invention relates to an improved process for the preparation of carvedilol or its pharmaceutical acceptable salts thereof. The present invention particularly relates to an improved process for the preparation and purification of 4-(oxiran-2-ylmethoxy)-9H-carbazole, an intermediate used in the preparation...
The present invention relates to an improved process for the preparation of Tranexamic acid or its pharmaceutically acceptable salts thereof.
The present invention discloses a novel process for the preparation of Lobeglitazone or its pharmaceutically acceptable salts. The invention also discloses a novel process for preparation of an intermediate compound 4-(2-{[6-(4-methoxyphenoxy)pyrimidin-4-yl]methylamino}ethoxy)benzaldehyde and further preparation of ...
The present invention is related to a method of determining Succinyl choline chloride in drug substance wherein eluting liquid that is moving phase comprises two liquids, A and B wherein liquid A comprises perchloric acid in water and liquid B is a combination of liquid A and an organic solvent. This novel methods o...
The present invention relates to an improved process for the preparation of sodium phenylbutyrate of formula-I and its intermediates thereof. The present invention provides a process for the preparation of sodium phenylbutyrate of Formula-I with less impurities. The invention also provides a novel process for the pr...
The present invention relates to a process for the preparation of cisatracurium besylate and its intermediates thereof. Particularly, the present invention relates to a process for the preparation of cisatracurium besylate that is commercially significant.
formula-I
The present invention relates to an improved process for the preparation of pure polyaminocarboxylate, particularly DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic Acid) that could be employed for the preparation of active pharmaceutical ingredients especially MRI contrast agents.
The present invention discloses a novel process for the preparation of omidenepag isopropyl having the structural Formula I. Preferably an improved process for the preparation of omidenepag isopropyl by reacting a compound of formula-III with a compound of formula-II in presence of a base in a suitable solvent to ob...
Registered Trademarks
[Class : 35] Retailing, Whole Selling, Advertising, Distribution Of Samples And Products, Sales Promotion, Business Management, Business Administration, Office Functions, Marketing Research, Import, Export, Distribution, Marketing And Trading Of Goods Relating To Pharmaceuticals, Medicinal, Dietary Feed Supplements And Nutraceuticals Included In Class 35
[Class : 5] Medicinal, Nutritional And Pharmaceutical Preparations And All Substances Included In Class 5
[Class : 5] Medicinal, Nutritional And
Pharmaceutical Preparations And All
Substances Included In Class 5
Charges
28 September 2022
Yes Bank Limited
0
28 September 2022
Yes Bank Limited
0
27 March 2018
Others
0
10 May 2018
Others
0
13 July 2018
Others
0
21 June 2018
Others
0
05 July 2018
Yes Bank Limited
0
20 December 2021
Others
0
30 May 2019
Others
0
22 November 2021
Others
0
29 November 2021
Others
0
01 November 2019
Others
0
12 November 2019
State Bank Of India
0
07 November 2020
Hdfc Bank Limited
0
21 June 2018
Others
0
21 January 2021
Others
0
30 June 2021
Others
0
28 June 2021
Others
0
25 June 2021
Others
0
22 July 2021
Hdfc Bank Limited
0
12 November 2019
State Bank Of India
0
25 June 2019
Others
0
25 March 2019
Others
0
07 November 2020
Hdfc Bank Limited
0
03 December 2018
Axis Bank Limited
0
28 September 2022
Yes Bank Limited
0
28 September 2022
Yes Bank Limited
0
27 March 2018
Others
0
10 May 2018
Others
0
13 July 2018
Others
0
21 June 2018
Others
0
05 July 2018
Yes Bank Limited
0
20 December 2021
Others
0
30 May 2019
Others
0
22 November 2021
Others
0
29 November 2021
Others
0
01 November 2019
Others
0
12 November 2019
State Bank Of India
0
07 November 2020
Hdfc Bank Limited
0
21 June 2018
Others
0
21 January 2021
Others
0
30 June 2021
Others
0
28 June 2021
Others
0
25 June 2021
Others
0
22 July 2021
Hdfc Bank Limited
0
12 November 2019
State Bank Of India
0
25 June 2019
Others
0
25 March 2019
Others
0
07 November 2020
Hdfc Bank Limited
0
03 December 2018
Axis Bank Limited
0
28 September 2022
Yes Bank Limited
0
28 September 2022
Yes Bank Limited
0
27 March 2018
Others
0
10 May 2018
Others
0
13 July 2018
Others
0
21 June 2018
Others
0
05 July 2018
Yes Bank Limited
0
20 December 2021
Others
0
30 May 2019
Others
0
22 November 2021
Others
0
29 November 2021
Others
0
01 November 2019
Others
0
12 November 2019
State Bank Of India
0
07 November 2020
Hdfc Bank Limited
0
21 June 2018
Others
0
21 January 2021
Others
0
30 June 2021
Others
0
28 June 2021
Others
0
25 June 2021
Others
0
22 July 2021
Hdfc Bank Limited
0
12 November 2019
State Bank Of India
0
25 June 2019
Others
0
25 March 2019
Others
0
07 November 2020
Hdfc Bank Limited
0
03 December 2018
Axis Bank Limited
0
